191 related articles for article (PubMed ID: 7745513)
21. Early or selective surfactant (colfosceril palmitate, Exosurf) for intubated babies at 26 to 29 weeks gestation. A European double-blind trial with sequential analysis. European Exosurf Study Group.
Online J Curr Clin Trials; 1992 Nov; Doc No 28():[3886 words; 47 paragraphs]. PubMed ID: 1343614
[TBL] [Abstract][Full Text] [Related]
22. Reduced mortality in small premature infants treated at birth with a single dose of synthetic surfactant.
Corbet AJ; Long WA; Murphy DJ; Garcia-Prats JA; Lombardy LR; Wold DE
J Paediatr Child Health; 1991 Aug; 27(4):245-9. PubMed ID: 1958425
[TBL] [Abstract][Full Text] [Related]
23. Comparison of the effect of three doses of a synthetic surfactant on the alveolar-arterial oxygen gradient in infants weighing > or = 1250 grams with respiratory distress syndrome. American Exosurf Neonatal Study Group II.
Berry DD; Pramanik AK; Philips JB; Buchter DS; Kanarek KS; Easa D; Kopelman AE; Edwards K; Long W
J Pediatr; 1994 Feb; 124(2):294-301. PubMed ID: 8301442
[TBL] [Abstract][Full Text] [Related]
24. Cost effects of surfactant therapy for neonatal respiratory distress syndrome.
Phibbs CS; Phibbs RH; Wakeley A; Schlueter MA; Sniderman S; Tooley WH
J Pediatr; 1993 Dec; 123(6):953-62. PubMed ID: 8229530
[TBL] [Abstract][Full Text] [Related]
25. Decreased mortality rate among small premature infants treated at birth with a single dose of synthetic surfactant: a multicenter controlled trial. American Exosurf Pediatric Study Group 1.
Corbet A; Bucciarelli R; Goldman S; Mammel M; Wold D; Long W
J Pediatr; 1991 Feb; 118(2):277-84. PubMed ID: 1993961
[TBL] [Abstract][Full Text] [Related]
26. Comparative trial of artificial and natural surfactants in the treatment of respiratory distress syndrome of prematurity: experiences in a developing country.
da Costa DE; Pai MG; Al Khusaiby SM
Pediatr Pulmonol; 1999 May; 27(5):312-7. PubMed ID: 10344709
[TBL] [Abstract][Full Text] [Related]
27. Comparative efficacy of exosurf and survanta surfactants on early clinical course of respiratory distress syndrome and complications of prematurity.
Modanlou HD; Beharry K; Padilla G; Norris K; Safvati S; Aranda JV
J Perinatol; 1997; 17(6):455-60. PubMed ID: 9447532
[TBL] [Abstract][Full Text] [Related]
28. Early versus delayed neonatal administration of a synthetic surfactant--the judgment of OSIRIS. The OSIRIS Collaborative Group (open study of infants at high risk of or with respiratory insufficiency--the role of surfactant.
Lancet; 1992 Dec; 340(8832):1363-9. PubMed ID: 1360087
[TBL] [Abstract][Full Text] [Related]
29. Exosurf treatment investigational new drug phase: effect of an individualized third dose in infants with respiratory distress syndrome.
Easa D; Pelke S; Nakamura KT; Barrett J; Balaraman V; Loo SW; Ibarra-Pratt E; Smith MB
Pediatr Pulmonol; 1992 Sep; 14(1):16-22. PubMed ID: 1437338
[TBL] [Abstract][Full Text] [Related]
30. Pulmonary hemorrhage in premature infants after treatment with synthetic surfactant: an autopsy evaluation. The American Exosurf Neonatal Study Group I, and the Canadian Exosurf Neonatal Study Group.
van Houten J; Long W; Mullett M; Finer N; Derleth D; McMurray B; Peliowski A; Walker D; Wold D; Sankaran K
J Pediatr; 1992 Feb; 120(2 Pt 2):S40-4. PubMed ID: 1735851
[TBL] [Abstract][Full Text] [Related]
31. Outcome at twelve months of adjusted age in very low birth weight infants with lung immaturity: a randomized, placebo-controlled trial of human surfactant.
Vaucher YE; Harker L; Merritt TA; Hallman M; Gist K; Bejar R; Heldt GP; Edwards D; Pohjavuori M
J Pediatr; 1993 Jan; 122(1):126-32. PubMed ID: 8419599
[TBL] [Abstract][Full Text] [Related]
32. Synthetic surfactant for rescue treatment of respiratory distress syndrome in premature infants weighing from 700 to 1350 grams: impact on hospital resource use and charges.
Mauskopf JA; Backhouse ME; Jones D; Wold DE; Mammel MC; Mullett M; Guthrie R; Long WA
J Pediatr; 1995 Jan; 126(1):94-101. PubMed ID: 7815233
[TBL] [Abstract][Full Text] [Related]
33. Energy expenditure during synthetic surfactant replacement therapy for neonatal respiratory distress syndrome.
Hazan J; Chessex P; Piedboeuf B; Bourgeois M; Bard H; Long W
J Pediatr; 1992 Feb; 120(2 Pt 2):S29-33. PubMed ID: 1735848
[TBL] [Abstract][Full Text] [Related]
34. Long-term pulmonary consequences of respiratory distress syndrome in preterm infants treated with exogenous surfactant.
Abbasi S; Bhutani VK; Gerdes JS
J Pediatr; 1993 Mar; 122(3):446-52. PubMed ID: 8441104
[TBL] [Abstract][Full Text] [Related]
35. A multicenter randomized trial comparing two surfactants for the treatment of neonatal respiratory distress syndrome. National Institute of Child Health and Human Development Neonatal Research Network.
Horbar JD; Wright LL; Soll RF; Wright EC; Fanaroff AA; Korones SB; Shankaran S; Oh W; Fletcher BD; Bauer CR
J Pediatr; 1993 Nov; 123(5):757-66. PubMed ID: 8229487
[TBL] [Abstract][Full Text] [Related]
36. Respiratory distress syndrome in New Zealand: evidence from the OSIRIS trial of exogenous surfactant (Exosurf).
Wach R; Darlow B; Bourchier D; Broadbent R; Knight D; Selby R
N Z Med J; 1994 Jun; 107(980):234-7. PubMed ID: 8208494
[TBL] [Abstract][Full Text] [Related]
37. A multicenter randomized, masked comparison trial of natural versus synthetic surfactant for the treatment of respiratory distress syndrome.
Hudak ML; Farrell EE; Rosenberg AA; Jung AL; Auten RL; Durand DJ; Horgan MJ; Buckwald S; Belcastro MR; Donohue PK; Carrion V; Maniscalco WW; Balsan MJ; Torres BA; Miller RR; Jansen RD; Graeber JE; Laskay KM; Matteson EJ; Egan EA; Brody AS; Martin DJ; Riddlesberger MM; Montgomery P
J Pediatr; 1996 Mar; 128(3):396-406. PubMed ID: 8774514
[TBL] [Abstract][Full Text] [Related]
38. [Natural and synthetic surfactant in the treatment of neonatal respiratory distress syndrome].
Bratlid D; Farstad T
Tidsskr Nor Laegeforen; 1994 Jan; 114(1):33-6. PubMed ID: 8296279
[TBL] [Abstract][Full Text] [Related]
39. Overview of clinical trials comparing natural and synthetic surfactants.
Halliday HL
Biol Neonate; 1995; 67 Suppl 1():32-47. PubMed ID: 7647157
[TBL] [Abstract][Full Text] [Related]
40. Elastase activity and surfactant protein concentration in tracheal aspirates from neonates receiving synthetic surfactant.
Gerdes J; Whitsett J; Long W
J Pediatr; 1992 Feb; 120(2 Pt 2):S34-9. PubMed ID: 1735850
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]